Mitral transcatheter edge-to-edge repair (M-TEER) reduced cardiovascular death and heart failure (HF)-related hospitalizations with improved health status in patients with HF and moderate to severe functional mitral regurgitation (FMR), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.
Transcatheter valve repair better than medical therapy in patients with heart failure and mitral regurgitation: Study retrieved 3 September 2024 from https://medicalxpress.com/news/2024-09-transcatheter-valve-medical-therapy-patients.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Sep 19, 2022Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Retrospective study explores mitral valve surgery outcomes in atrial functional mitral regurgitationMitral regurgitation (MR) is a serious heart condition that often requires corrective surgery. It is characterized by the backflow or 'regurgitation' of blood from the heart's left ventricle into the left atrium.
Read more »
Transcatheter edge-to-edge repair found non-inferior to surgery in patients with secondary mitral regurgitationThere was no difference in efficacy between transcatheter edge-to-edge repair (TEER) and surgery in patients with secondary mitral regurgitation (MR), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024. The findings are published in the New England Journal of Medicine.
Read more »
MATTERHORN trial finds TEER non-inferior to surgery for secondary mitral regurgitationThere was no difference in efficacy between transcatheter edge-to-edge repair (TEER) and surgery in patients with secondary mitral regurgitation (MR), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.
Read more »
RESHAPE-HF2 trial shows M-TEER as effective treatment for functional mitral regurgitationMitral transcatheter edge-to-edge repair (M-TEER) reduced cardiovascular death and heart failure (HF)-related hospitalizations with improved health status in patients with HF and moderate to severe functional mitral regurgitation (FMR), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.
Read more »
New evidence for benefits of transcatheter edge-to-edge repair in secondary tricuspid regurgitationTricuspid transcatheter edge-to-edge repair (T-TEER) significantly reduced the severity of secondary tricuspid regurgitation and improved quality of life after one year, according to research presented in a Hot Line session August 31 at ESC Congress 2024.
Read more »
Oral anticoagulants should be paused before transcatheter aortic valve implantation, researchers sayThere was no apparent benefit to continuing oral anticoagulants compared with interruption in patients undergoing transcatheter aortic valve implantation (TAVI), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024. The study is published in the New England Journal of Medicine.
Read more »